Princeton, NJ (PRWEB) August 30, 2013
Leveraging LIS (laboratory information system) technology to provide a competitive edge will be the theme of a presentation by NovoPath VP of Sales and Marketing, Rick Callahan, at the American Society of Clinical Pathology (ASCP) Meeting in September in Chicago. As part of the event’s innovative Science Connection-themed exhibit hall, Callahan will showcase the value of NovoPath Anatomic Pathology (AP) LIS in helping labs to address the demands of today’s challenging patient care and business environments. He joins other event exhibitors in providing attendees with learning opportunities focusing on innovative methods of enhancing lab quality, productivity and efficiency to promote profitability and drive better patient care.
“Today’s anatomic pathology environment requires all AP professionals to be nimble enough to adapt to the ever changing conditions and test menu offerings,” says Callahan. “Labs must be more efficient and make the most of their resources to carve a new niche in today’s demanding healthcare world.” Callahan points out that those laboratories have been significantly challenged by diminished reimbursements for many frequently used Anatomic Pathology procedures, the systematic reduction in Medicare Part B Clinical Laboratory Fee Schedules and more.
Intelligent use of technology, he says, can help lab personnel better take advantage of their time to fill in the gaps. Moreover, some LIS solutions incorporate business tools to help labs analyze their internal operations and guide them in decision-making and mapping out a new course to address the pressing issues ahead.
Recognizing this, NovoPath will demonstrate its Lean Process Improvement module designed to analyze existing data to help labs find new operational efficiencies in everyday workflows. Lean Process accesses and analyzes information about every step in each aspect of lab workflow as performed by individual lab workers at their assigned workstations. Lean Process analysis identifies workflow bottlenecks and inefficiencies and helps eliminate extra or redundant steps, while benchmarking staff performance.
Also demonstrated at ASCP 2013 will be NovoOutreach, a unique electronic order entry and results viewing platform. NovoOutreach integrates with a lab’s existing website to create a sophisticated web portal. The module will seamlessly deliver results in the format of the referring physician’s choice. These can be sent directly into a physician’s EMR or practice management system. They can also be delivered to smartphones, tablets, WAN, e-mail, fax voice, FTP and much more. NovoOutreach includes a powerful HL7 interface engine that can handle thousands of simultaneous connections.
NovoPath combines highly specialized modules such as these with traditional surgical pathology and cytology testing functionalities to offer labs integrated CP and AP results reporting. Among these core functionalities are a rapid accessioning process using bar code technology, seamless interfaces to a HIS, EMR, practice management and any additional systems utilized to associate a test request with the patient sample. It also includes the ability to document, capture and distribute test results.
ASCP attendees will also have the opportunity to see how NovoPath can customize its technologies to meet the specific needs of all individual labs.
About NovoPath, Inc.
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, and in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.